Patrick Hwu: Could targeting T cell metabolism be the next big thing in boosting cancer immunotherapy?
Patrick Hwu, President and CEO of Moffitt Cancer Center, shared an article by KayLee Steiner et al, on LinkedIn:
“Could targeting T cell metabolism be the next big thing in boosting cancer immunotherapy?
New research shows tweaking how T cells use fat can change their survival and power.
In this study, KayLee Steiner, Jeffrey Rathmell et. al found that a gene called MECR helps T cells get the energy they need to fight disease. Without MECR, T cells struggle to survive and do their job.
By understanding these metabolic pathways, we might find new ways to make cancer-fighting T cells even stronger!
Exciting possibilities ahead!
Mitochondrial fatty acid synthesis and MECR regulate CD4+ T cell function and oxidative metabolism
Authors: KayLee K Steiner, Jeffrey Rathmell,et al.
More posts featuring Patrick Hwu.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023